You are viewing an old version of this page. View the current version.

Compare with Current View Page History

Version 1 Next »

  1. The lab parameters that should be collected are not specified by CDASH, as this is a medical and scientific decision that is based on the needs of the protocol.
  2. Sponsors should decide which scenario is appropriate for each protocol.
  3. As required or defined by the study protocol, clinically significant results may need to be reported on the Medical History or Adverse Event CRF.
  4. As required or defined by the study protocol, changes that are worsening may need to be reported on the AE CRF.
  5. All pertinent laboratory normal ranges/units and laboratory certification for all laboratories used during the study will be provided to the sponsor. This is required for regulatory and database purposes.
  6. This is a specimen-based domain. LBDTC is the date the specimen was collected.
  7. LOINC code should not be applied to local lab data by the sponsor. LOINC codes are intended to come directly from the central laboratory.
  • No labels